Robert Lisicki - 27 Feb 2025 Form 4 Insider Report for Zura Bio Ltd (ZURA)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: ZURA
Reported as of: 27 Feb 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Mar 2025, 17:01:42 UTC
Prior SEC filing: 24 Jan 2025
Source filing: View source filing
Reporting owner signature: /s/ Robert Lisicki

Key filing fact

Robert Lisicki filed Form 4 for Zura Bio Ltd (ZURA) on 03 Mar 2025.

Key facts

This page summarizes Robert Lisicki's Form 4 filing for Zura Bio Ltd (ZURA).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 03 Mar 2025, 17:01.

Change

Previous filing in this sequence was filed on 24 Jan 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ZURA transaction Derivative

Employee Share Option (Right to Buy)

Award

Transaction value: $0
Shares: +1,153,000
Change %
Price: $0.000000
Shares after: 1,153,000
Date: 27 Feb 2025
Ownership: Direct
Underlying class: Class A Ordinary Shares
Underlying amount: 1,153,000
Exercise price: $1.20
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

One fourth (1/4th) of the shares subject to the option award shall vest on February 27, 2026, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.